DK158724C - Analogifremgangsmaade til fremstilling af 5-phenylhydantoinderivater eller farmaceutisk acceptable salte deraf - Google Patents

Analogifremgangsmaade til fremstilling af 5-phenylhydantoinderivater eller farmaceutisk acceptable salte deraf

Info

Publication number
DK158724C
DK158724C DK499983A DK499983A DK158724C DK 158724 C DK158724 C DK 158724C DK 499983 A DK499983 A DK 499983A DK 499983 A DK499983 A DK 499983A DK 158724 C DK158724 C DK 158724C
Authority
DK
Denmark
Prior art keywords
analogue
phenyl
preparation
acceptable salts
pharmaceutical acceptable
Prior art date
Application number
DK499983A
Other languages
English (en)
Other versions
DK499983A (da
DK158724B (da
DK499983D0 (da
Inventor
James P Rizzi
Rodney C Schnur
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK499983D0 publication Critical patent/DK499983D0/da
Publication of DK499983A publication Critical patent/DK499983A/da
Publication of DK158724B publication Critical patent/DK158724B/da
Application granted granted Critical
Publication of DK158724C publication Critical patent/DK158724C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/76Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/76Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C07D233/78Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK499983A 1982-11-01 1983-11-01 Analogifremgangsmaade til fremstilling af 5-phenylhydantoinderivater eller farmaceutisk acceptable salte deraf DK158724C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/438,199 US4452806A (en) 1982-11-01 1982-11-01 Treating diabetic complications with 5-(substituted phenyl)hydantoins
US43819982 1982-11-01

Publications (4)

Publication Number Publication Date
DK499983D0 DK499983D0 (da) 1983-11-01
DK499983A DK499983A (da) 1984-05-02
DK158724B DK158724B (da) 1990-07-09
DK158724C true DK158724C (da) 1990-11-19

Family

ID=23739660

Family Applications (1)

Application Number Title Priority Date Filing Date
DK499983A DK158724C (da) 1982-11-01 1983-11-01 Analogifremgangsmaade til fremstilling af 5-phenylhydantoinderivater eller farmaceutisk acceptable salte deraf

Country Status (13)

Country Link
US (1) US4452806A (da)
JP (1) JPS5998063A (da)
KR (1) KR860001507B1 (da)
CA (1) CA1203241A (da)
DK (1) DK158724C (da)
ES (1) ES526841A0 (da)
FI (1) FI80265C (da)
GR (1) GR79638B (da)
HU (1) HU191887B (da)
PL (1) PL139646B1 (da)
PT (1) PT77578A (da)
YU (1) YU43556B (da)
ZA (1) ZA838092B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1321980A4 (en) 2000-09-25 2007-04-04 Ibiden Co Ltd SEMICONDUCTOR ELEMENT, METHOD FOR MANUFACTURING SEMICONDUCTOR ELEMENT, MULTILAYER PRINTED CIRCUIT BOARD, AND METHOD FOR MANUFACTURING MULTILAYER PRINTED CIRCUIT BOARD
IT1319201B1 (it) * 2000-10-12 2003-09-26 Nicox Sa Farmaci per il diabete.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2814256A1 (de) * 1977-04-05 1978-10-12 Ciba Geigy Ag Schmieroelzusatzstoffe
FR2458546A1 (fr) * 1979-06-07 1981-01-02 Hoechst France Procede de fabrication d'aryl-5 hydantoines racemiques et produits nouveaux en resultant

Also Published As

Publication number Publication date
DK499983A (da) 1984-05-02
ES8507119A1 (es) 1985-05-01
FI833993A0 (fi) 1983-10-31
YU43556B (en) 1989-08-31
HU191887B (en) 1987-04-28
KR860001507B1 (ko) 1986-09-30
PL244350A1 (en) 1985-02-13
DK158724B (da) 1990-07-09
PL139646B1 (en) 1987-02-28
FI833993A (fi) 1984-05-02
US4452806A (en) 1984-06-05
ZA838092B (en) 1985-06-26
ES526841A0 (es) 1985-05-01
KR840006630A (ko) 1984-12-01
DK499983D0 (da) 1983-11-01
YU216783A (en) 1986-02-28
FI80265C (fi) 1990-05-10
PT77578A (en) 1983-11-01
JPS5998063A (ja) 1984-06-06
JPH0465832B2 (da) 1992-10-21
FI80265B (fi) 1990-01-31
GR79638B (da) 1984-10-31
CA1203241A (en) 1986-04-15

Similar Documents

Publication Publication Date Title
DK161770C (da) Analogifremgangsmaade til fremstilling af cyklobutylaminderivater eller farmaceutisk acceptable salte deraf
DK160940C (da) Analogifremgangsmaade til fremstilling af benzoheterocycliske forbindelser eller farmaceutisk acceptable salte deraf
DK149449C (da) Analogifremgangsmaade til fremstilling af carbostyrilderivater eller farmaceutisk acceptable salte deraf
DK152495C (da) Analogifremgangsmaade til fremstilling af n2-arylsulfonyl-l-argininamider eller farmaceutisk tolerable salte deraf
DK163359C (da) Analogifremgangsmaade til fremstilling af n-imidazolylderivater af bicycliske forbindelser eller pharmaceutisk acceptable salte deraf
DK163244C (da) Analogifremgangsmaade til fremstilling af 7-oe2-(2-aminothiazol-4-yl)-2-oxyimino-acetamidoaa-ceph-3-em-4-carboxylsyrederivater eller fysiologisk acceptable salte deraf
DK152114C (da) Analogifremgangsmaade til fremstilling af propenylaminer eller farmaceutisk acceptable salte deraf
DK161968C (da) Analogifremgangsmaade til fremstilling af imidazo-pyrazolo-pyrimidiner eller farmaceutisk acceptable salte deraf
DK158269C (da) Analogifremgangsmaade til fremstilling af morpholinyldaunorubicin- eller morpholinyldoxorubicinderivater
DK148537C (da) Analogifremgangsmaade til fremstilling af 3-aminopyridazinforbindelser eller farmaceutisk acceptable salte deraf
DK158306C (da) Analogifremgangsmaade til fremstilling af substituerede pyridylallylforbindelser eller farmaceutisk acceptable salte deraf
DK162166C (da) Analogifremgangsmaade til fremstilling af (2s)-isomere af 2-oe4-(2-hydroxycyclopentan-1-ylmethyl)phenylaapropionsyre eller farmaceutisk acceptable salte deraf
DK158658C (da) Analogifremgangsmaade til fremstilling af 9-aminoalkylfluorener eller farmaceutisk acceptable salte deraf
DK161699C (da) Analogifremgangsmaade til fremstilling af 4-aryl-4-piperidincarbinoler eller farmaceutisk acceptable salte deraf
DK155670C (da) Analogifremgangsmaade til fremstilling af sesquiterpenderivater eller farmaceutisk acceptable salte deraf
DK149269C (da) Analogifremgangsmaade til fremstilling af beta-mono- eller -difluormethyl-beta-alanin-derivater eller farmaceutisk acceptable salte eller optiske isomere deraf
DK413883D0 (da) Fremgangsmade til fremstilling af c-20-modificerede macrolid-derivater eller farmaceutisk acceptable salte deraf
DK145263C (da) Analogifremgangsmaade til fremstilling af imidazothiaziner eller farmaceutisk acceptable salte deraf
DK165005C (da) Analogifremgangsmaade til fremstilling af 4,5-dihydro-4-oxofuran-2-carboxylsyrederivater eller terapeutisk acceptable salte deraf
DK149093C (da) Analogifremgangsmaade til fremstilling af pentapeptidderivater eller farmaceutisk acceptable salte deraf
DK158227C (da) Analogifremgangsmaade til fremstilling af substituerede imidazooe1,5-aaapyridiner eller 5,6,7,8-tetrahydroderivater deraf eller salte deraf
DK162102C (da) Analogifremgangsmaade til fremstilling af 3-o-(beta-d-glucoronopyranosyl)-sojasapogenol b eller farmaceutisk acceptable salte deraf
DK152491C (da) Analogifremgangsmaade til fremstilling af esterholdige phenoxypropanolaminer eller farmaceutisk anvendelige salte deraf
DK148019C (da) Analogifremgangsmaade til fremstilling af 2-pyridylaminobenzoesyrer eller farmaceutisk acceptable salte deraf
DK150521C (da) Analogifremgangsmaade til fremstilling af n2-arylsulfonyl-l-argininamider eller farmaceutisk acceptable salte deraf

Legal Events

Date Code Title Description
PBP Patent lapsed